BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 445410)

  • 1. Effect of hepatocarcinogens on the adenine purine nucleotide cycle during the initiation phase of carcinogenesis.
    Smith LD; Emerson RL; Nixon LK
    Cancer Res; 1979 Jun; 39(6 Pt 1):2132-8. PubMed ID: 445410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenine purine nucleotide cycle enzymes and 3' -methyl-4-dimethylaminoazobenzene injections.
    Smith LD; Emerson RL
    Int J Biochem; 1978; 9(5):323-6. PubMed ID: 97106
    [No Abstract]   [Full Text] [Related]  

  • 3. SAMP lyase and AMP deaminase activity in rat parenchymal and kupffer cells in hepatocarcinogenesis.
    Smith LD; Lewis EL; Morrical SW; Butler M
    Int J Biochem; 1984; 16(9):985-90. PubMed ID: 6479436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The purine nucleotide cycle (author's transl)].
    Makarewicz W
    Postepy Biochem; 1979; 25(2):169-95. PubMed ID: 228258
    [No Abstract]   [Full Text] [Related]  

  • 5. Enzymes of the purine ribonucleotide cycle in rat hepatomas and kidney tumors.
    Jackson RC; Morris HP; Weber G
    Cancer Res; 1977 Sep; 37(9):3057-65. PubMed ID: 195718
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzymes of the purine nucleotide cycle in muscle of patients with exercise intolerance.
    Operti MG; Vincent MF; Brucher JM; van den Berghe G
    Muscle Nerve; 1998 Mar; 21(3):401-3. PubMed ID: 9486871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of the purine nucleotide cycle in extracts of rat skeletal muscle: effects of energy state and concentrations of cycle intermediates.
    Manfredi JP; Holmes EW
    Arch Biochem Biophys; 1984 Sep; 233(2):515-29. PubMed ID: 6486798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of the bovine genes of the de novo AMP synthesis pathway.
    Bønsdorff T; Gautier M; Farstad W; Rønningen K; Lingaas F; Olsaker I
    Anim Genet; 2004 Dec; 35(6):438-44. PubMed ID: 15566465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alterations in epidermal growth factor binding to hepatic membranes following dietary exposure of rats to known hepatocarcinogens.
    Ringer DP; Panzeter PL; DeCicco LA
    Toxicol Lett; 1997 Mar; 91(1):7-12. PubMed ID: 9096280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymes of purine metabolism in human and rat renal cortex and renal cell carcinoma.
    Jackson RC; Goulding FJ; Weber G
    J Natl Cancer Inst; 1979 Apr; 62(4):749-54. PubMed ID: 285288
    [No Abstract]   [Full Text] [Related]  

  • 11. Nitro analogs of substrates for adenylosuccinate synthetase and adenylosuccinate lyase.
    Porter DJ; Rudie NG; Bright HJ
    Arch Biochem Biophys; 1983 Aug; 225(1):157-63. PubMed ID: 6351751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of the purine nucleotide cycle in rat pancreatic islets.
    Marynissen G; Sener A; Malaisse WJ
    Biochem Med Metab Biol; 1992 Oct; 48(2):127-36. PubMed ID: 1419144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specificity of adenylosuccinate synthetase and adenylosuccinate lyase from Leishmania donovani. Selective amination of an antiprotozoal agent.
    Spector T; Jones TE; Elion GB
    J Biol Chem; 1979 Sep; 254(17):8422-6. PubMed ID: 468834
    [No Abstract]   [Full Text] [Related]  

  • 14. Purine de novo synthesis and enzymes at the inosinic branch point in human lymphocytes.
    Marinello E; Pagani R; Carlucci F; Pizzichini M; Valerio P; Molinelli M; Dispensa E; Tabucchi A
    Biochem Soc Trans; 1991 Aug; 19(3):343S. PubMed ID: 1723703
    [No Abstract]   [Full Text] [Related]  

  • 15. Adenylosuccinate synthetase and adenylosuccinate lyase from Trypanosoma cruzi, Specificity studies with potential chemotherapeutic agents.
    Spector T; Berens RL; Marr JJ
    Biochem Pharmacol; 1982 Jan; 31(2):225-9. PubMed ID: 7037007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased purine nucleotide cycle activity associated with dietary zinc deficiency.
    Brody MS; Steinberg JR; Svingen BA; Luecke RW
    Biochem Biophys Res Commun; 1977 Sep; 78(1):144-50. PubMed ID: 907666
    [No Abstract]   [Full Text] [Related]  

  • 17. Lack of evidence for isozymic shifts of adenylate deaminase during hepatocarcinogenesis.
    Nixon LK; Smith LD
    Comp Biochem Physiol C Comp Pharmacol; 1980; 65(2):123-8. PubMed ID: 6102001
    [No Abstract]   [Full Text] [Related]  

  • 18. Species-specific effects of the hepatocarcinogens 3'-methyl-4-dimethyl-aminoazobenzene and ortho-aminoazotoluene in mouse and rat liver.
    Merkulova TI; Kropachev KY; Timofeeva OA; Vasiliev GV; Levashova ZB; Ilnitskaya SI; Kobzev VF; Pakharukova MY; Bryzgalov LO; Kaledin VI
    Mol Carcinog; 2005 Dec; 44(4):223-32. PubMed ID: 16267830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purine nucleotide cycle enzymes in dystrophic and normal mouse muscle.
    Fitt PS; Parliament MB
    Biosci Rep; 1982 Mar; 2(3):177-83. PubMed ID: 7066489
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute effects of selected hepatocarcinogens on polyribosomes and protein synthesis in the livers of rats fed purified diets containing hepatocarcinogens.
    Sidransky H; Verney E
    Cancer Res; 1978 Apr; 38(4):1166-72. PubMed ID: 639043
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.